

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.85889439 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.72774035 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.53710880 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.53710880 |
| 5 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 5.35105703 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.08929850 |
| 7 | B cell receptor signaling pathway (GO:0050853) | 5.05729553 |
| 8 | T-helper 1 type immune response (GO:0042088) | 4.95113639 |
| 9 | positive regulation of B cell differentiation (GO:0045579) | 4.81090548 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.75762292 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 4.71306363 |
| 12 | T cell lineage commitment (GO:0002360) | 4.66823271 |
| 13 | regulation of B cell differentiation (GO:0045577) | 4.55986040 |
| 14 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 4.51470221 |
| 15 | positive regulation of humoral immune response (GO:0002922) | 4.45546346 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.37039038 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.37039038 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.37039038 |
| 19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.37039038 |
| 20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.37039038 |
| 21 | modulation by symbiont of host immune response (GO:0052553) | 4.37039038 |
| 22 | cellular response to zinc ion (GO:0071294) | 4.29291486 |
| 23 | cytidine metabolic process (GO:0046087) | 4.18819363 |
| 24 | cytidine catabolic process (GO:0006216) | 4.18819363 |
| 25 | cytidine deamination (GO:0009972) | 4.18819363 |
| 26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.13785379 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.10440019 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.04712945 |
| 29 | defense response to protozoan (GO:0042832) | 3.95023621 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.93410036 |
| 31 | detection of bacterium (GO:0016045) | 3.86553404 |
| 32 | negative T cell selection (GO:0043383) | 3.84016552 |
| 33 | cellular response to interferon-gamma (GO:0071346) | 3.68389669 |
| 34 | positive regulation of macrophage cytokine production (GO:0060907) | 3.66209710 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.66034289 |
| 36 | T cell costimulation (GO:0031295) | 3.65983077 |
| 37 | mast cell activation (GO:0045576) | 3.63435941 |
| 38 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.62719799 |
| 39 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.61492310 |
| 40 | response to protozoan (GO:0001562) | 3.61060072 |
| 41 | lymphocyte costimulation (GO:0031294) | 3.60595108 |
| 42 | negative regulation of cell killing (GO:0031342) | 3.59526516 |
| 43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.59526516 |
| 44 | negative regulation of phagocytosis (GO:0050765) | 3.58912196 |
| 45 | respiratory burst (GO:0045730) | 3.55962070 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.55616404 |
| 47 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.53807208 |
| 48 | positive thymic T cell selection (GO:0045059) | 3.46146502 |
| 49 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45656768 |
| 50 | thymic T cell selection (GO:0045061) | 3.45447412 |
| 51 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.44706593 |
| 52 | positive regulation of B cell proliferation (GO:0030890) | 3.43508529 |
| 53 | positive regulation of B cell mediated immunity (GO:0002714) | 3.43175820 |
| 54 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.43175820 |
| 55 | detection of other organism (GO:0098543) | 3.40498587 |
| 56 | mature B cell differentiation (GO:0002335) | 3.38135528 |
| 57 | cellular response to interleukin-15 (GO:0071350) | 3.37650185 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.31636417 |
| 59 | activation of MAPKKK activity (GO:0000185) | 3.30645045 |
| 60 | response to host immune response (GO:0052572) | 3.30439712 |
| 61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.30439712 |
| 62 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.29404851 |
| 63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.27535067 |
| 64 | B cell mediated immunity (GO:0019724) | 3.27481844 |
| 65 | regulation of protein heterodimerization activity (GO:0043497) | 3.26587722 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26443539 |
| 67 | viral transcription (GO:0019083) | 3.25469599 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24384441 |
| 69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.21988155 |
| 70 | response to type I interferon (GO:0034340) | 3.17337693 |
| 71 | mature B cell differentiation involved in immune response (GO:0002313) | 3.17252619 |
| 72 | cellular response to type I interferon (GO:0071357) | 3.16757496 |
| 73 | type I interferon signaling pathway (GO:0060337) | 3.16757496 |
| 74 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.14519588 |
| 75 | myeloid dendritic cell activation (GO:0001773) | 3.13352389 |
| 76 | cellular response to interferon-beta (GO:0035458) | 3.13261365 |
| 77 | leukocyte aggregation (GO:0070486) | 3.12338502 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.12007694 |
| 79 | translational termination (GO:0006415) | 3.11012688 |
| 80 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.10594091 |
| 81 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.10118605 |
| 82 | response to interferon-gamma (GO:0034341) | 3.07780944 |
| 83 | response to interferon-beta (GO:0035456) | 3.05146398 |
| 84 | neutrophil activation (GO:0042119) | 3.04676582 |
| 85 | T cell homeostasis (GO:0043029) | 3.04512910 |
| 86 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.03671767 |
| 87 | NIK/NF-kappaB signaling (GO:0038061) | 3.02943436 |
| 88 | regulation of germinal center formation (GO:0002634) | 3.02431365 |
| 89 | negative regulation of B cell apoptotic process (GO:0002903) | 2.99068038 |
| 90 | response to host (GO:0075136) | 2.97598829 |
| 91 | response to host defenses (GO:0052200) | 2.97598829 |
| 92 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.97598829 |
| 93 | mast cell degranulation (GO:0043303) | 2.97218969 |
| 94 | mast cell activation involved in immune response (GO:0002279) | 2.97218969 |
| 95 | positive regulation of protein homooligomerization (GO:0032464) | 2.95902471 |
| 96 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.94917334 |
| 97 | T cell migration (GO:0072678) | 2.93726348 |
| 98 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.93567767 |
| 99 | negative regulation of bone resorption (GO:0045779) | 2.92568603 |
| 100 | positive regulation of protein oligomerization (GO:0032461) | 2.91740113 |
| 101 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.89934039 |
| 102 | positive regulation of interleukin-12 production (GO:0032735) | 2.89067819 |
| 103 | positive regulation of interferon-alpha production (GO:0032727) | 2.88791860 |
| 104 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.88415854 |
| 105 | megakaryocyte development (GO:0035855) | 2.87463884 |
| 106 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.85700891 |
| 107 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.85233662 |
| 108 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.83498475 |
| 109 | B cell proliferation (GO:0042100) | 2.82721990 |
| 110 | angiogenesis involved in wound healing (GO:0060055) | 2.81436530 |
| 111 | myeloid cell activation involved in immune response (GO:0002275) | 2.81231583 |
| 112 | cotranslational protein targeting to membrane (GO:0006613) | 2.77950967 |
| 113 | regulation of interferon-alpha production (GO:0032647) | 2.77688129 |
| 114 | protein targeting to ER (GO:0045047) | 2.76592879 |
| 115 | granulocyte activation (GO:0036230) | 2.76185303 |
| 116 | * lymphocyte homeostasis (GO:0002260) | 2.74607807 |
| 117 | response to interleukin-15 (GO:0070672) | 2.74533943 |
| 118 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.72577228 |
| 119 | cellular response to exogenous dsRNA (GO:0071360) | 2.71408632 |
| 120 | B cell activation (GO:0042113) | 2.71375032 |
| 121 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70541323 |
| 122 | ribosomal small subunit biogenesis (GO:0042274) | 2.69948910 |
| 123 | regulation of B cell apoptotic process (GO:0002902) | 2.67103613 |
| 124 | * regulation of B cell proliferation (GO:0030888) | 2.66240587 |
| 125 | lymph node development (GO:0048535) | 2.66067716 |
| 126 | myeloid dendritic cell differentiation (GO:0043011) | 2.65019735 |
| 127 | macrophage activation involved in immune response (GO:0002281) | 2.64936530 |
| 128 | response to peptidoglycan (GO:0032494) | 2.64151697 |
| 129 | regulation of antigen processing and presentation (GO:0002577) | 2.63628741 |
| 130 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.63188819 |
| 131 | translational elongation (GO:0006414) | 2.62849656 |
| 132 | * leukocyte homeostasis (GO:0001776) | 2.61833461 |
| 133 | protein localization to endoplasmic reticulum (GO:0070972) | 2.61339686 |
| 134 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.61262273 |
| 135 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.61006932 |
| 136 | positive regulation of B cell activation (GO:0050871) | 2.60550649 |
| 137 | regulation of necroptotic process (GO:0060544) | 2.59848536 |
| 138 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.59340835 |
| 139 | telomere maintenance via recombination (GO:0000722) | 2.58786046 |
| 140 | * regulation of B cell activation (GO:0050864) | 2.57145297 |
| 141 | germinal center formation (GO:0002467) | 2.56872796 |
| 142 | necroptotic process (GO:0070266) | 2.56226606 |
| 143 | definitive hemopoiesis (GO:0060216) | 2.55972973 |
| 144 | response to muramyl dipeptide (GO:0032495) | 2.55912559 |
| 145 | * negative regulation of B cell proliferation (GO:0030889) | 2.55576308 |
| 146 | DNA strand elongation (GO:0022616) | 2.55123883 |
| 147 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.54483213 |
| 148 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.52350429 |
| 149 | negative thymic T cell selection (GO:0045060) | 2.51382213 |
| 150 | actin nucleation (GO:0045010) | 2.50968430 |
| 151 | DNA deamination (GO:0045006) | 2.50757473 |
| 152 | * B cell homeostasis (GO:0001782) | 2.50138307 |
| 153 | positive regulation of interleukin-2 production (GO:0032743) | 2.48466633 |
| 154 | positive regulation of macrophage differentiation (GO:0045651) | 2.47890714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.61249061 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.36388295 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.12587846 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.95890864 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.95335118 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44320803 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.42906294 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.29297023 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01183184 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.91779546 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.86281993 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.85343865 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.80262501 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.62976920 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61745172 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.60263413 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.51685190 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.46036625 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.44131907 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40869115 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.39180360 |
| 22 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36019939 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.35658856 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32249607 |
| 25 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30410139 |
| 26 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 2.30382823 |
| 27 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28080275 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.26672153 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.24929345 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.13075124 |
| 31 | * MAF_26560356_Chip-Seq_TH1_Human | 2.08854623 |
| 32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.08279199 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.07607393 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.06226589 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03079981 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01834683 |
| 37 | * MYB_26560356_Chip-Seq_TH1_Human | 2.01276066 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.97109311 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95889145 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94284707 |
| 41 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.92402902 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91157288 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80348261 |
| 44 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79814767 |
| 45 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.76921644 |
| 46 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73735593 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73083490 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72476775 |
| 49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.69053734 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68661283 |
| 51 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68514643 |
| 52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67394450 |
| 53 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.60068057 |
| 54 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.57804900 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53942209 |
| 56 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.52808207 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.50882226 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50502703 |
| 59 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.49976956 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.47599879 |
| 61 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47258021 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44255414 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41492596 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40314056 |
| 65 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36831507 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35851858 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.34373776 |
| 68 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33836467 |
| 69 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.31789637 |
| 70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31226707 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30476477 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.29323468 |
| 73 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.27132346 |
| 74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.24279186 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21898961 |
| 76 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.19588927 |
| 77 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.18169716 |
| 78 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17982677 |
| 79 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.16903598 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16741366 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16464239 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16391303 |
| 83 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.15270162 |
| 84 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.13345310 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11951579 |
| 86 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.11313550 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11222590 |
| 88 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11195179 |
| 89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11164549 |
| 90 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.08342564 |
| 91 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08283201 |
| 92 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06988542 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06816492 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06558860 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05970961 |
| 96 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05634868 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05082243 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02088338 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01835954 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01140508 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00143483 |
| 102 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.00034572 |
| 103 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.99814020 |
| 104 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.99605483 |
| 105 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.97968615 |
| 106 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96193308 |
| 107 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95943245 |
| 108 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.95751769 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94563334 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92488396 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91684998 |
| 112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90607071 |
| 113 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89737483 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89664390 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89291864 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89286505 |
| 117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89229657 |
| 118 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.89077783 |
| 119 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89008425 |
| 120 | P300_27268052_Chip-Seq_Bcells_Human | 0.88775016 |
| 121 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87974496 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87849808 |
| 123 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.87792703 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87522445 |
| 125 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.87385794 |
| 126 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.84831662 |
| 127 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.84225076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.19798161 |
| 2 | * MP0001800_abnormal_humoral_immune | 3.53442072 |
| 3 | MP0005671_abnormal_response_to | 3.38093796 |
| 4 | MP0000685_abnormal_immune_system | 3.33832560 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 3.32434908 |
| 6 | MP0001790_abnormal_immune_system | 3.23494958 |
| 7 | MP0005387_immune_system_phenotype | 3.23494958 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.19093011 |
| 9 | * MP0002452_abnormal_antigen_presenting | 3.10096708 |
| 10 | MP0009785_altered_susceptibility_to | 3.08615829 |
| 11 | * MP0005000_abnormal_immune_tolerance | 3.00076587 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.99069722 |
| 13 | * MP0002723_abnormal_immune_serum | 2.84477811 |
| 14 | MP0003436_decreased_susceptibility_to | 2.83112355 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.80770328 |
| 16 | MP0005025_abnormal_response_to | 2.78771435 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.78442362 |
| 18 | * MP0001819_abnormal_immune_cell | 2.77097094 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.65858923 |
| 20 | MP0002419_abnormal_innate_immunity | 2.54232633 |
| 21 | MP0003303_peritoneal_inflammation | 2.47970108 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.45110855 |
| 23 | * MP0000716_abnormal_immune_system | 2.40245009 |
| 24 | * MP0000689_abnormal_spleen_morphology | 2.29646560 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.22708777 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.20584020 |
| 27 | MP0001853_heart_inflammation | 2.16900903 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 2.14270790 |
| 29 | * MP0002722_abnormal_immune_system | 2.09810654 |
| 30 | * MP0002429_abnormal_blood_cell | 2.06697170 |
| 31 | MP0010155_abnormal_intestine_physiology | 2.01880201 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 2.01314265 |
| 33 | MP0001348_abnormal_lacrimal_gland | 2.00187273 |
| 34 | MP0002405_respiratory_system_inflammati | 1.99926559 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.93544039 |
| 36 | MP0001873_stomach_inflammation | 1.87553455 |
| 37 | MP0002006_tumorigenesis | 1.86005693 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.85819718 |
| 39 | MP0003724_increased_susceptibility_to | 1.78852300 |
| 40 | * MP0001845_abnormal_inflammatory_respons | 1.78144937 |
| 41 | MP0003045_fibrosis | 1.75314567 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.74435563 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.74435563 |
| 44 | MP0008057_abnormal_DNA_replication | 1.66507033 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.64364677 |
| 46 | MP0000490_abnormal_crypts_of | 1.63918118 |
| 47 | MP0003866_abnormal_defecation | 1.62651880 |
| 48 | MP0002163_abnormal_gland_morphology | 1.57271024 |
| 49 | MP0005451_abnormal_body_composition | 1.55960442 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.55266060 |
| 51 | MP0006082_CNS_inflammation | 1.54169181 |
| 52 | MP0003693_abnormal_embryo_hatching | 1.52884849 |
| 53 | MP0004947_skin_inflammation | 1.50707961 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.48457387 |
| 55 | MP0000372_irregular_coat_pigmentation | 1.43010315 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 1.38789590 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.33157656 |
| 58 | MP0003077_abnormal_cell_cycle | 1.32068106 |
| 59 | MP0008469_abnormal_protein_level | 1.30110604 |
| 60 | MP0002933_joint_inflammation | 1.27427386 |
| 61 | MP0005310_abnormal_salivary_gland | 1.24505783 |
| 62 | * MP0002019_abnormal_tumor_incidence | 1.23334440 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.21608747 |
| 64 | MP0002095_abnormal_skin_pigmentation | 1.15862804 |
| 65 | MP0008058_abnormal_DNA_repair | 1.14106020 |
| 66 | MP0008007_abnormal_cellular_replicative | 1.12908071 |
| 67 | MP0009046_muscle_twitch | 1.11829109 |
| 68 | MP0004510_myositis | 1.10230636 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.10012473 |
| 70 | MP0005623_abnormal_meninges_morphology | 1.09289404 |
| 71 | MP0002928_abnormal_bile_duct | 1.08724184 |
| 72 | MP0009278_abnormal_bone_marrow | 1.08199555 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.07870025 |
| 74 | MP0000015_abnormal_ear_pigmentation | 1.06383708 |
| 75 | MP0000858_altered_metastatic_potential | 1.05432166 |
| 76 | MP0002139_abnormal_hepatobiliary_system | 1.03982916 |
| 77 | MP0006054_spinal_hemorrhage | 1.01941833 |
| 78 | MP0003646_muscle_fatigue | 1.01444920 |
| 79 | MP0001986_abnormal_taste_sensitivity | 1.01345526 |
| 80 | MP0005058_abnormal_lysosome_morphology | 1.01246815 |
| 81 | MP0003111_abnormal_nucleus_morphology | 1.00700800 |
| 82 | MP0010307_abnormal_tumor_latency | 0.98611055 |
| 83 | MP0009764_decreased_sensitivity_to | 0.93555954 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.90236350 |
| 85 | MP0003448_altered_tumor_morphology | 0.87244480 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.84702946 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.84589373 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 0.84446003 |
| 89 | MP0000343_altered_response_to | 0.82324808 |
| 90 | MP0000313_abnormal_cell_death | 0.80865990 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79655739 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.77773272 |
| 93 | MP0008874_decreased_physiological_sensi | 0.77276392 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.73279871 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 0.71988557 |
| 96 | MP0001663_abnormal_digestive_system | 0.71411706 |
| 97 | MP0009763_increased_sensitivity_to | 0.71369714 |
| 98 | MP0003091_abnormal_cell_migration | 0.71368694 |
| 99 | MP0002132_abnormal_respiratory_system | 0.69749753 |
| 100 | MP0008872_abnormal_physiological_respon | 0.68343523 |
| 101 | MP0008569_lethality_at_weaning | 0.68114226 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 0.67578557 |
| 103 | MP0003828_pulmonary_edema | 0.67260645 |
| 104 | MP0000371_diluted_coat_color | 0.66654413 |
| 105 | MP0003252_abnormal_bile_duct | 0.62630407 |
| 106 | MP0004036_abnormal_muscle_relaxation | 0.61863327 |
| 107 | MP0002106_abnormal_muscle_physiology | 0.61089880 |
| 108 | MP0005084_abnormal_gallbladder_morpholo | 0.59918116 |
| 109 | MP0000249_abnormal_blood_vessel | 0.59748042 |
| 110 | MP0000759_abnormal_skeletal_muscle | 0.59741952 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 0.59412226 |
| 112 | MP0003075_altered_response_to | 0.58929310 |
| 113 | MP0001727_abnormal_embryo_implantation | 0.57044159 |
| 114 | MP0000350_abnormal_cell_proliferation | 0.56959848 |
| 115 | MP0001851_eye_inflammation | 0.56716427 |
| 116 | MP0008873_increased_physiological_sensi | 0.56409360 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.56335126 |
| 118 | MP0001879_abnormal_lymphatic_vessel | 0.55454765 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.55313408 |
| 120 | * MP0002136_abnormal_kidney_physiology | 0.53662541 |
| 121 | MP0005166_decreased_susceptibility_to | 0.53484661 |
| 122 | MP0003186_abnormal_redox_activity | 0.52610967 |
| 123 | MP0010352_gastrointestinal_tract_polyps | 0.52405655 |
| 124 | MP0005330_cardiomyopathy | 0.52032736 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50863623 |
| 126 | MP0000477_abnormal_intestine_morphology | 0.50527078 |
| 127 | MP0000569_abnormal_digit_pigmentation | 0.50061896 |
| 128 | MP0002168_other_aberrant_phenotype | 0.50027211 |
| 129 | * MP0002083_premature_death | 0.49511923 |
| 130 | MP0005266_abnormal_metabolism | 0.49175853 |
| 131 | MP0002009_preneoplasia | 0.48237194 |
| 132 | MP0000598_abnormal_liver_morphology | 0.47804583 |
| 133 | MP0005499_abnormal_olfactory_system | 0.47404111 |
| 134 | MP0005394_taste/olfaction_phenotype | 0.47404111 |
| 135 | MP0009765_abnormal_xenobiotic_induced | 0.46957026 |
| 136 | MP0000747_muscle_weakness | 0.43289004 |
| 137 | MP0003795_abnormal_bone_structure | 0.43227149 |
| 138 | MP0003786_premature_aging | 0.42546546 |
| 139 | MP0002332_abnormal_exercise_endurance | 0.42191737 |
| 140 | MP0000749_muscle_degeneration | 0.41756858 |
| 141 | MP0002837_dystrophic_cardiac_calcinosis | 0.41678718 |
| 142 | MP0004087_abnormal_muscle_fiber | 0.40970586 |
| 143 | MP0000003_abnormal_adipose_tissue | 0.40132566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 5.78316454 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.16734405 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.09737501 |
| 4 | Cellulitis (HP:0100658) | 4.87448086 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.69849868 |
| 6 | Recurrent viral infections (HP:0004429) | 4.61717948 |
| 7 | Thrombocytosis (HP:0001894) | 4.58139072 |
| 8 | Chronic otitis media (HP:0000389) | 4.47060100 |
| 9 | * Recurrent bronchitis (HP:0002837) | 4.45097369 |
| 10 | Myositis (HP:0100614) | 4.37807047 |
| 11 | * IgM deficiency (HP:0002850) | 4.16973536 |
| 12 | Colitis (HP:0002583) | 4.13373873 |
| 13 | * Meningitis (HP:0001287) | 4.12171445 |
| 14 | Eczematoid dermatitis (HP:0000976) | 4.11133077 |
| 15 | Abnormality of B cell number (HP:0010975) | 4.04123295 |
| 16 | B lymphocytopenia (HP:0010976) | 4.04123295 |
| 17 | * Gastrointestinal stroma tumor (HP:0100723) | 3.91317714 |
| 18 | Inflammation of the large intestine (HP:0002037) | 3.90545179 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 3.84552252 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.75862359 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.74863503 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.73197843 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65616882 |
| 24 | Basal cell carcinoma (HP:0002671) | 3.59578348 |
| 25 | * Recurrent sinusitis (HP:0011108) | 3.54895916 |
| 26 | Recurrent skin infections (HP:0001581) | 3.52913667 |
| 27 | Dry hair (HP:0011359) | 3.45895299 |
| 28 | * Vasculitis (HP:0002633) | 3.36737902 |
| 29 | * Lymphopenia (HP:0001888) | 3.34899665 |
| 30 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.25730068 |
| 31 | Chronic sinusitis (HP:0011109) | 3.23321620 |
| 32 | Squamous cell carcinoma (HP:0002860) | 3.18473298 |
| 33 | Papilloma (HP:0012740) | 3.17733488 |
| 34 | Verrucae (HP:0200043) | 3.17733488 |
| 35 | Osteomyelitis (HP:0002754) | 3.16737004 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16151437 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16151437 |
| 38 | Obstructive lung disease (HP:0006536) | 3.11380413 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 3.11380413 |
| 40 | * Recurrent pneumonia (HP:0006532) | 3.08087995 |
| 41 | Petechiae (HP:0000967) | 3.07771789 |
| 42 | Interstitial pulmonary disease (HP:0006530) | 3.05024587 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.99810655 |
| 44 | * Abnormality of T cell physiology (HP:0011840) | 2.99050133 |
| 45 | * IgG deficiency (HP:0004315) | 2.97978420 |
| 46 | Rhabdomyolysis (HP:0003201) | 2.97352315 |
| 47 | Abnormality of macrophages (HP:0004311) | 2.96195658 |
| 48 | Thyroiditis (HP:0100646) | 2.93532968 |
| 49 | * Recurrent lower respiratory tract infections (HP:0002783) | 2.92460560 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.91934535 |
| 51 | * Abnormality of T cells (HP:0002843) | 2.87937143 |
| 52 | Increased IgM level (HP:0003496) | 2.86581881 |
| 53 | Orchitis (HP:0100796) | 2.76892516 |
| 54 | Optic neuritis (HP:0100653) | 2.72309460 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.72309460 |
| 56 | Nasal polyposis (HP:0100582) | 2.70156455 |
| 57 | Onycholysis (HP:0001806) | 2.66891968 |
| 58 | Myoglobinuria (HP:0002913) | 2.65548705 |
| 59 | Premature loss of primary teeth (HP:0006323) | 2.65068076 |
| 60 | Exercise-induced myalgia (HP:0003738) | 2.63476795 |
| 61 | Sepsis (HP:0100806) | 2.61186740 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.59116043 |
| 63 | Hypertensive crisis (HP:0100735) | 2.57589865 |
| 64 | Conical tooth (HP:0000698) | 2.57492451 |
| 65 | Viral hepatitis (HP:0006562) | 2.55934551 |
| 66 | Reticulocytopenia (HP:0001896) | 2.52716195 |
| 67 | T lymphocytopenia (HP:0005403) | 2.49972617 |
| 68 | * Lymphoma (HP:0002665) | 2.49729721 |
| 69 | Xerostomia (HP:0000217) | 2.49535734 |
| 70 | Encephalitis (HP:0002383) | 2.49256090 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 2.48203212 |
| 72 | * Emphysema (HP:0002097) | 2.47813342 |
| 73 | Abnormality of T cell number (HP:0011839) | 2.47286565 |
| 74 | Pulmonary infiltrates (HP:0002113) | 2.46344236 |
| 75 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.45595210 |
| 76 | Abnormality of the nasal mucosa (HP:0000433) | 2.45470104 |
| 77 | Skin rash (HP:0000988) | 2.45348648 |
| 78 | Abnormal number of erythroid precursors (HP:0012131) | 2.44236280 |
| 79 | Chronic diarrhea (HP:0002028) | 2.42344302 |
| 80 | Stomatitis (HP:0010280) | 2.39592610 |
| 81 | * Bronchitis (HP:0012387) | 2.34686408 |
| 82 | Abnormality of the prostate (HP:0008775) | 2.34374450 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.34275120 |
| 84 | * IgA deficiency (HP:0002720) | 2.34264501 |
| 85 | Hepatitis (HP:0012115) | 2.33556777 |
| 86 | Pustule (HP:0200039) | 2.33507656 |
| 87 | * Recurrent otitis media (HP:0000403) | 2.33392454 |
| 88 | Neutropenia (HP:0001875) | 2.33353705 |
| 89 | Abnormal gallbladder physiology (HP:0012438) | 2.32368096 |
| 90 | Cholecystitis (HP:0001082) | 2.32368096 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 2.24250646 |
| 92 | Epistaxis (HP:0000421) | 2.23449872 |
| 93 | Skin ulcer (HP:0200042) | 2.22292566 |
| 94 | Exercise-induced muscle cramps (HP:0003710) | 2.21887377 |
| 95 | * Leukopenia (HP:0001882) | 2.19339844 |
| 96 | Chest pain (HP:0100749) | 2.17724599 |
| 97 | Ridged nail (HP:0001807) | 2.17643571 |
| 98 | Leukocytosis (HP:0001974) | 2.16552409 |
| 99 | Vacuolated lymphocytes (HP:0001922) | 2.15760854 |
| 100 | Granulocytopenia (HP:0001913) | 2.14959384 |
| 101 | Aplastic anemia (HP:0001915) | 2.14708291 |
| 102 | Fatigue (HP:0012378) | 2.14240768 |
| 103 | Acute hepatic failure (HP:0006554) | 2.13860909 |
| 104 | Abnormality of the fingertips (HP:0001211) | 2.13003660 |
| 105 | Periodontitis (HP:0000704) | 2.12815284 |
| 106 | Basal ganglia calcification (HP:0002135) | 2.12493831 |
| 107 | Sparse scalp hair (HP:0002209) | 2.12093426 |
| 108 | * Restrictive lung disease (HP:0002091) | 2.11361500 |
| 109 | Abnormality of incisor morphology (HP:0011063) | 2.10242971 |
| 110 | Eosinophilia (HP:0001880) | 2.09038259 |
| 111 | Urticaria (HP:0001025) | 2.06503909 |
| 112 | Gingivitis (HP:0000230) | 2.06401988 |
| 113 | Keratoconjunctivitis sicca (HP:0001097) | 2.06179383 |
| 114 | Increased IgE level (HP:0003212) | 2.04828545 |
| 115 | Severe combined immunodeficiency (HP:0004430) | 2.04476989 |
| 116 | Combined immunodeficiency (HP:0005387) | 2.02829703 |
| 117 | Arterial thrombosis (HP:0004420) | 2.02577291 |
| 118 | Abnormality of male internal genitalia (HP:0000022) | 2.01691495 |
| 119 | Poikiloderma (HP:0001029) | 2.01295139 |
| 120 | Pulmonary fibrosis (HP:0002206) | 2.00070889 |
| 121 | * Arthralgia (HP:0002829) | 1.99864063 |
| 122 | Erythema (HP:0010783) | 1.98995486 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 1.98590109 |
| 124 | Hemoptysis (HP:0002105) | 1.98297846 |
| 125 | Abnormality of eosinophils (HP:0001879) | 1.97991562 |
| 126 | Abnormality of the pleura (HP:0002103) | 1.96542390 |
| 127 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91443479 |
| 128 | Abnormality of lateral ventricle (HP:0030047) | 1.83208289 |
| 129 | Acrocyanosis (HP:0001063) | 1.83140067 |
| 130 | Teleangiectasia of the skin (HP:0100585) | 1.81841124 |
| 131 | Deep palmar crease (HP:0006191) | 1.79235435 |
| 132 | Ragged-red muscle fibers (HP:0003200) | 1.71920357 |
| 133 | Muscle fiber inclusion bodies (HP:0100299) | 1.71509261 |
| 134 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71091962 |
| 135 | Impaired proprioception (HP:0010831) | 1.69927373 |
| 136 | * Bronchiectasis (HP:0002110) | 1.64223435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.39911816 |
| 2 | PRPF4B | 3.43148677 |
| 3 | KIT | 2.89658833 |
| 4 | CSF1R | 2.75942491 |
| 5 | BLK | 2.75361250 |
| 6 | RIPK4 | 2.61134340 |
| 7 | SMG1 | 2.59813076 |
| 8 | BTK | 2.59787910 |
| 9 | IRAK4 | 2.53744832 |
| 10 | SYK | 2.34653474 |
| 11 | TYK2 | 2.33970311 |
| 12 | ERN1 | 2.23785535 |
| 13 | TEC | 2.23286494 |
| 14 | TBK1 | 2.20746275 |
| 15 | MAP3K14 | 2.10432727 |
| 16 | IRAK3 | 2.08063322 |
| 17 | ZAK | 2.01930829 |
| 18 | EEF2K | 1.96745117 |
| 19 | JAK3 | 1.92842155 |
| 20 | MAP3K10 | 1.89476295 |
| 21 | FLT3 | 1.82162319 |
| 22 | ZAP70 | 1.80871591 |
| 23 | IKBKE | 1.79582927 |
| 24 | TXK | 1.67850547 |
| 25 | GRK6 | 1.67334193 |
| 26 | NME2 | 1.62442546 |
| 27 | IKBKB | 1.60517687 |
| 28 | STK10 | 1.58041201 |
| 29 | ACVR1B | 1.54673794 |
| 30 | LYN | 1.53203611 |
| 31 | MAP3K9 | 1.51336592 |
| 32 | EIF2AK1 | 1.47791169 |
| 33 | DAPK3 | 1.43431562 |
| 34 | FGFR4 | 1.39570801 |
| 35 | MAP3K13 | 1.31910198 |
| 36 | ITK | 1.30786432 |
| 37 | LCK | 1.30772392 |
| 38 | FES | 1.30250792 |
| 39 | LRRK2 | 1.28655742 |
| 40 | HCK | 1.27180007 |
| 41 | CLK1 | 1.25875469 |
| 42 | PIM1 | 1.20429984 |
| 43 | RPS6KA5 | 1.19352253 |
| 44 | TAOK3 | 1.19096450 |
| 45 | PIM2 | 1.15113079 |
| 46 | JAK1 | 1.14533497 |
| 47 | RPS6KA4 | 1.13909099 |
| 48 | ARAF | 1.12568075 |
| 49 | MAP2K3 | 1.12408392 |
| 50 | VRK2 | 1.09171033 |
| 51 | MATK | 1.08870286 |
| 52 | TAF1 | 1.07799378 |
| 53 | TGFBR1 | 1.06659129 |
| 54 | TGFBR2 | 1.03600807 |
| 55 | EIF2AK3 | 1.02700609 |
| 56 | OBSCN | 1.00974901 |
| 57 | STK24 | 0.99588662 |
| 58 | NME1 | 0.99295021 |
| 59 | STK4 | 0.98675859 |
| 60 | NEK1 | 0.98455757 |
| 61 | NEK2 | 0.96809849 |
| 62 | CDK12 | 0.96409493 |
| 63 | SIK3 | 0.92928081 |
| 64 | MAPK12 | 0.92569864 |
| 65 | CDK19 | 0.92308085 |
| 66 | CSK | 0.91780010 |
| 67 | BCKDK | 0.91519690 |
| 68 | STK16 | 0.89915117 |
| 69 | SIK2 | 0.85997120 |
| 70 | CHUK | 0.79216092 |
| 71 | RPS6KB2 | 0.77419329 |
| 72 | MAP3K12 | 0.76728592 |
| 73 | MARK3 | 0.76651975 |
| 74 | MAPK7 | 0.76563675 |
| 75 | NLK | 0.76428732 |
| 76 | BRAF | 0.75229551 |
| 77 | PRKCH | 0.74146878 |
| 78 | CDK4 | 0.73957912 |
| 79 | WEE1 | 0.68703909 |
| 80 | MST4 | 0.67153448 |
| 81 | VRK1 | 0.66548625 |
| 82 | BRSK2 | 0.65496324 |
| 83 | MELK | 0.65115797 |
| 84 | BUB1 | 0.64897122 |
| 85 | PKN1 | 0.63532025 |
| 86 | ATR | 0.61355267 |
| 87 | NEK9 | 0.60943803 |
| 88 | AURKA | 0.58476761 |
| 89 | TESK2 | 0.57986522 |
| 90 | CDK9 | 0.57790835 |
| 91 | TNIK | 0.57519214 |
| 92 | CDC7 | 0.57417460 |
| 93 | MAPKAPK3 | 0.57160938 |
| 94 | CCNB1 | 0.57063905 |
| 95 | TLK1 | 0.56149215 |
| 96 | MAPKAPK5 | 0.55025199 |
| 97 | DYRK3 | 0.53855343 |
| 98 | CDC42BPA | 0.50250115 |
| 99 | KDR | 0.48283518 |
| 100 | JAK2 | 0.47572797 |
| 101 | MAP3K11 | 0.46728501 |
| 102 | PRKCQ | 0.46288112 |
| 103 | MAPK4 | 0.45858946 |
| 104 | TRPM7 | 0.44417502 |
| 105 | TNK2 | 0.44011112 |
| 106 | YES1 | 0.43786764 |
| 107 | HIPK2 | 0.42877611 |
| 108 | SCYL2 | 0.42690175 |
| 109 | ABL1 | 0.41861448 |
| 110 | PRKCI | 0.41813626 |
| 111 | ADRBK2 | 0.41530447 |
| 112 | MAP3K8 | 0.40710815 |
| 113 | RAF1 | 0.40288252 |
| 114 | BMPR2 | 0.40023402 |
| 115 | PKN2 | 0.38678141 |
| 116 | RPS6KA6 | 0.38264940 |
| 117 | BRSK1 | 0.37582696 |
| 118 | ALK | 0.35183382 |
| 119 | PDPK1 | 0.35119724 |
| 120 | MAPK11 | 0.34968593 |
| 121 | PDK1 | 0.34583795 |
| 122 | FGFR3 | 0.34449210 |
| 123 | MAPKAPK2 | 0.33488600 |
| 124 | PRKCD | 0.33274124 |
| 125 | FGR | 0.32171850 |
| 126 | CDK6 | 0.32115609 |
| 127 | PASK | 0.32041053 |
| 128 | EIF2AK2 | 0.31620094 |
| 129 | AKT2 | 0.31281775 |
| 130 | PIK3CG | 0.30781237 |
| 131 | MAP4K2 | 0.29086251 |
| 132 | DDR2 | 0.28438775 |
| 133 | RPS6KL1 | 0.26988008 |
| 134 | RPS6KC1 | 0.26988008 |
| 135 | CHEK1 | 0.26875660 |
| 136 | AURKB | 0.25880974 |
| 137 | NUAK1 | 0.23577554 |
| 138 | CHEK2 | 0.22679659 |
| 139 | INSR | 0.22519502 |
| 140 | TRIB3 | 0.21427318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 3.89306570 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.28511066 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.98956466 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.54783378 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.50722917 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.50166317 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.40824387 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.39590559 |
| 9 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36460147 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.29991985 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.29801938 |
| 12 | Alcoholism_Homo sapiens_hsa05034 | 2.28202692 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 2.20185235 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.08201609 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05561785 |
| 16 | Measles_Homo sapiens_hsa05162 | 2.01728150 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98639776 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.88981228 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87139953 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.83144230 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81206862 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75855875 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75503920 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.61301292 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.53055072 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48550488 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48522421 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.44709516 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.43561243 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40801643 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38299458 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37589901 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36955949 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.30077302 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27245270 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.22890973 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20539645 |
| 38 | Spliceosome_Homo sapiens_hsa03040 | 1.19898350 |
| 39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.17851086 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.16888356 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.15666262 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.13890090 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09505745 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09207786 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06807738 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06233435 |
| 47 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05006950 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.03330917 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03304263 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01081902 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00538340 |
| 52 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.99940974 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96268771 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.96018094 |
| 55 | Proteasome_Homo sapiens_hsa03050 | 0.94322089 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93669361 |
| 57 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93513222 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90031345 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89196205 |
| 60 | Cell cycle_Homo sapiens_hsa04110 | 0.87188287 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86741769 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.86320103 |
| 63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84904287 |
| 64 | Protein export_Homo sapiens_hsa03060 | 0.82494058 |
| 65 | RNA degradation_Homo sapiens_hsa03018 | 0.82289552 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79271582 |
| 67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.77173043 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77041098 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76716271 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76605128 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70591920 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70104839 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69698669 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.68889216 |
| 75 | RNA polymerase_Homo sapiens_hsa03020 | 0.67856122 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66856267 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65136108 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63247595 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63058684 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61362531 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60724236 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59554716 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.59476225 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58516653 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58052936 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.57173320 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56637726 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54782998 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54464883 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50603600 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50378880 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48901669 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45237373 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44412853 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.44050744 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42869074 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40636213 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40083096 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39463025 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37379107 |
| 101 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37225962 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35194061 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35084408 |
| 104 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34408941 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34287263 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33475474 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33281932 |
| 108 | Basal transcription factors_Homo sapiens_hsa03022 | 0.33127244 |
| 109 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.30049426 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29493936 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.28358583 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25819200 |
| 113 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.24241994 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.20818800 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.15875016 |
| 116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.14930196 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14765526 |
| 118 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.10581872 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09386695 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.08172062 |
| 121 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.06679890 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.05367830 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.03553096 |
| 124 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.02418767 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.02166685 |
| 126 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.01904804 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.01364243 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.00835223 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | -0.0383717 |

